Bruker (NASDAQ: BRKR) net income
Bruker reported a net loss of $8.6m for fiscal 2025; in fiscal 2024 it reported a net profit of $113.1m. Earnings per share were −$0.15.
Bruker's net income has fallen for 2 years in a row, and its best year of the last 10 was fiscal 2023. The biggest drop was in fiscal 2024, −73.5%. It reported a loss in 1 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$8.6m | −107.6% | −0.3% | −$0.15 |
| 2024 | $113.1m | −73.5% | 3.4% | $0.76 |
| 2023 | $427.2m | +44.0% | 14.4% | $2.92 |
| 2022 | $296.6m | +7.0% | 11.7% | $2.00 |
| 2021 | $277.1m | +75.6% | 11.5% | $1.83 |
| 2020 | $157.8m | −20.0% | 7.9% | $1.03 |
| 2019 | $197.2m | +9.7% | 9.5% | $1.27 |
| 2018 | $179.7m | +128.6% | 9.5% | $1.15 |
| 2017 | $78.6m | −48.8% | 4.5% | $0.50 |
| 2016 | $153.6m | — | 9.5% | $0.95 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Bruker net income compared with its sector
By net income for its latest fiscal year, Bruker ranks 188th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Bruker, −0.3%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 186th | Stoke Therapeutics | −$6.9m | −3.7% |
| 187th | Neogen | −$7.9m | −0.9% |
| 188th | Bruker | −$8.6m | −0.3% |
| 189th | Cronos Group | −$9.4m | −4.9% |
| 190th | Century Therapeutics | −$9.6m | −8.8% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Bruker
- How much did Bruker earn in fiscal 2025?
- Bruker reported a net loss of $8.6m for fiscal 2025. In fiscal 2024 it reported a net profit of $113.1m.
- What are the earnings per share of Bruker?
- They were −$0.15 in fiscal 2025, compared with $0.76 in fiscal 2024.
- What was the most profitable year for Bruker?
- Of its last 10 fiscal years, fiscal 2023, with $427.2m.
- Where does Bruker rank in its sector by net income?
- It ranks 188th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Bruker come from?
- From the annual report (Form 10-K) that Bruker files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Bruker files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Bruker: the Bruker page · annual accounts · revenue · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.